Intelligence · Clinical Pipeline
Eli Lilly and Pipeline
All ClinicalTrials.gov programs at Eli Lilly and — phase, modality, and trial IDs.
- Programs
- 3
Quick answer
Eli Lilly and has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
ADALIMUMAB, BARICITINIB, BARICITINIB, ADALIMUMAB, ETANERCEPT
Eli Lilly Co.
Rheumatoid Arthritis
1 trial -
Omvoh 100 mg solution for injection in pre-filled syringe, Omvoh 100 mg + 200 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solutio
Eli Lilly Co.
severely active ulcerative colitis (US) and CD (Crohn’s disease)
1 trial -
SELPERCATINIB, SELPERCATINIB
Eli Lilly Co.
Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;
1 trial
Frequently asked questions
How many pipeline programs does Eli Lilly and have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs